Autoimmune & Inflammatory Research
Rheumatoid Arthritis Clinical Research
Rheumatoid Arthritis (RA) is a chronic autoimmune disease that causes inflammation, joint pain, stiffness, and fatigue. CenExel partners with sponsors to advance innovative RA treatments through expert clinical research, experienced investigators, and access to diverse patient populations across multiple research sites.
Studies Conducted
0
+
Trial Participants
0
+
Active Sites
0
+
Overview
Advancing Rheumatoid Arthritis Research
CenExel provides specialized scientific and operational support for Rheumatoid Arthritis clinical trials. Our experienced research teams focus on improving treatment outcomes through patient-centered studies, advanced biomarkers, and efficient enrollment strategies.
Conditions Covered
Rheumatoid Arthritis Conditions We Research
Our rheumatology research sites support a wide range of autoimmune and inflammatory disorders related to rheumatoid arthritis and chronic joint inflammation.
- Rheumatoid Arthritis (RA)
- Moderate-to-Severe RA
- Early Rheumatoid Arthritis
- Psoriatic Arthritis
- Juvenile Idiopathic Arthritis
- Ankylosing Spondylitis
- Osteoarthritis
- Lupus-Related Arthritis
Our Approach
Why Sponsors Choose CenExel for Rheumatoid Arthritis
CenExel combines scientific expertise, advanced clinical operations, and strong patient recruitment strategies to support successful rheumatoid arthritis clinical trials.
01
Experienced Rheumatology Investigators
Our physicians and research teams have extensive experience managing autoimmune and inflammatory disease studies.
02
Advanced Biomarker & Imaging Support
We support trials requiring biomarker analysis, imaging assessments, and complex efficacy endpoints.
03
Diverse Patient Access
Access to broad patient populations across multiple research locations improves enrollment speed and diversity.
04
Efficient Trial Execution
Our integrated operational approach helps reduce delays and maintain high-quality study performance.
Phase Coverage
Supported Rheumatology Trial Phases
CenExel supports rheumatoid arthritis research from first-in-human studies through Phase IV post-market clinical trials.
Active across all phases
- Phase I
- Phase II
- Phase III
- Phase IV
Our research teams support biologics, biosimilars, small molecules, and emerging autoimmune therapies with experienced clinical oversight.
Rheumatology Task Force
CenExel supports rheumatology and autoimmune clinical research across multiple specialized sites with experienced investigators and diverse patient populations.
Active Sites
18 Sites
CenExel Phoenix
CenExel Anaheim
CenExel Atlanta
CenExel Marlton
CenExel Gaithersburg
